UBS’s NEOPHOTONICS CORP NPTN Stock Holding History

UBS’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-1,573	Closed	-$12.2K	–	10814
2013 Q2	$14K	Buy	+1,573	New	+$10.1K	﹤0.01%	8286

Other funds holding NPTN

Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Adirondack Research & Management Guilderland, New York $82.2M AUM 63.78% 1-Year Est. Return

Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Quentec Asset Management New York $634M AUM 22.87% 1-Year Est. Return

White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS's NPTN Position: Q3 2013 in Review

UBS sold out of NEOPHOTONICS CORP (NPTN) in Q3 2013, closing a stake of 1,573 shares — an estimated $12.2K sold.

UBS first reported a position in NPTN in Q2 2013 and held it in 1 quarter. The position peaked at $14K in Q2 2013. 72 funds tracked by Wall St. Rank hold NPTN as of Q3 2013.

UBS reported no remaining NEOPHOTONICS CORP position as of Q3 2013 after selling out during the quarter.
UBS sold 1,573 NEOPHOTONICS CORP shares in Q3 2013, an estimated $12.2K.
UBS first reported a position in NEOPHOTONICS CORP in Q2 2013 and held it in 1 quarter.
UBS's NEOPHOTONICS CORP position peaked at $14K in Q2 2013.
72 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2013.

Based on UBS's 13F filing for Q3 2013, filed 13 Nov 2013.